Search Results
Leveraging Targeted Therapies to Improve Outcomes Across the Continuum of HER2+ Breast Cancer
Sequencing HER2-targeted therapies in breast cancer
Personalizing Treatment Decisions in HER2-Altered Breast Cancer
Novel therapies for HER2+ metastatic breast cancer
Navigating Shifts in the Treatment Landscape for Metastatic HER2-Positive Breast Cancer
Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani
3-year DFS in randomized trials of chemotherapy and HER2-targeted therapy
Treatment Updated for HER2 Positive Breast Cancer: Changing Paradigms
Dr. Hurvitz on HER2-Targeted Therapies in Breast Cancer
Selecting Third-Line Therapy to Treat HER2+ De Novo Metastatic Breast Cancer
Dr. Hurvitz Discusses De-Escalation in HER2+ Breast Cancer
Novel targeted therapies in breast cancer
